Intelligent Healthcare, a core journal of the “Intelligent Medical Journal Series”, dedicated to accelerate the translation of artificial-intelligence discoveries into equitable, data-driven, and human-centered solutions that advance smart hospitals, elevate digital healthcare, and redefine global health ecosystems.
The “Intelligent Medical Journal Series” is a collection of international, peer-reviewed, open-access academic journals dedicated to advancing the deep integration of artificial intelligence and related technologies within specific medical and healthcare disciplines. Our mission is to publish high-quality, impactful research that bridges the gap between technological innovation and clinical application.
● Duplicate Publication and Plagiarism We only accept original, unpublished manuscripts that have not been submitted simultaneously to other journals. By submitting a manuscript, authors agree to this policy. As defined by the World Association of Medical Editors (WAME http://www.wame.org/resources/publication-ethics-policies-for-medical-journals), plagiarism is the use of others' published or unpublished ideas, words, or other intellectual property without attribution or permission. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies whether the material is taken from abstracts, research grants, or published or unpublished manuscripts. The editorial office uses plagiarism detection software, such as iThenticate, to screen all submissions. Any allegations of plagiarism are investigated in accordance with the Committee on Publication Ethics (COPE) guidelines (see https://publicationethics.org/files/u7140/plagiarism%20A.pdf). If plagiarism is detected at any point, appropriate actions will be taken, which may include notifying the authors' institution and funding agencies, and potentially retracting the published paper. For additional information, please visit http://www.publicationethics.org.
● Conflicts of Interest Disclosure All authors must disclose any potential conflicts of interest, including financial, consulting, institutional, or other relationships that could lead to bias. If there are no conflicts of interest, this must be explicitly stated. All sources of funding must be acknowledged in the manuscript.
○ Disclosure Content: Please create a section titled "Conflicts of Interest and Funding" below the title page. For example: “Conflicts of Interest and Funding: Author A has received honoraria from Company Z. Author B is currently receiving a grant (#12345) from Organization Y and is on the speaker's bureau for Company A. The remaining authors declare no conflicts of interest.”
● Protection of Patients' Rights to Privacy Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines: 1. Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices. 2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.
● Data Availability Statement Data Availability Statement should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. Where research data are not publicly available, this must be stated in the manuscript along with any conditions for accessing the data. Data Availability Statements should take one of the following forms (or a combination of more than one if required for multiple types of research data):
○ The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS].
○ The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
○ The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
○ Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
○ All data generated or analyzed during this study are included in this published article [and its supplementary information files].
○ The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].
● Ethical Oversight for AI Studies Manuscripts involving artificial intelligence or machine learning must clearly describe the data sources, model validation, and measures to prevent algorithmic bias, in accordance with relevant AI ethics guidelines.
● Authorship and Contribution Each person listed as an author must have made a substantial intellectual contribution to the intellectual content, data analysis, and/or writing of the manuscript and be able to take public responsibility for it. All authors must have reviewed and approved the final submitted manuscript.
○ Please list each author's specific contributions in a footnote. We recommend using the CRediT (Contributor Roles Taxonomy) standard, such as "Conceptualization," "Methodology," "Data Curation," "Writing – original draft," and "Supervision," to clearly define each author's role.
● Human and Animal Studies Manuscripts involving human subjects must be conducted in accordance with the ethical principles of the Declaration of Helsinki, and informed consent must be obtained. Animal experiments must comply with the ARRIVE guidelines and adhere to relevant local and international animal welfare regulations.
○ Ethics Approval: Authors must explicitly state in the manuscript that they have obtained approval from an Institutional Review Board (or Ethics Committee) and provide the approval number.
● Clinical Trial Registration “Intelligent Medical Journal Series” would publish clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable:
○ http://www.clinicaltrials.gov/
○ http://www.trialregister.nl/trialreg/index.asp
● Reporting Guidelines To ensure scientific rigor and transparency, we recommend that authors follow relevant reporting guidelines for their field, such as:
○ CONSORT: Reports of randomized clinical trials should follow the recommendations given in the Consolidated Standards of Reported Trials (CONSORT) statement http://www.consort-statement.org
○ PRISMA – Preferred Reporting Items for Systematic Reviews and Meta-Analyses http://www.prisma-statement.org
○ STROBE – Strengthening the Reporting of Observational studies in Epidemiology http://www.strobe-statement.org
○ STEGA – Strengthening the Reporting of Genetic Associations http://www.med.uottawa.ca/public-health-genomics/web/eng/strega.html
○ CARE – Strengthening the Reporting of Case Reports https://www.care-statement.org/checklist
● Single-Blind Peer Review We operate a single-blind review process where reviewers' identities are hidden from the authors, but authors' identities are known to the reviewers. This helps ensure reviewers provide candid, unbiased feedback.
○ Initial Screening: The editorial office will initially screen all submissions to assess their originality, scientific rigor, and relevance to the journal. Manuscripts that do not meet the criteria will be rejected at this stage without undergoing formal peer review.
○ Expert Review: Manuscripts that pass the initial screening will be sent to at least two independent experts for review. Reviewers will provide detailed feedback on the manuscript's scientific quality, analysis, novelty, and significance.
○ Editorial Decision: The Editor-in-Chief will make a final decision (Accept, Minor Revisions, Major Revisions, or Reject) based on the reviewers' comments.
○ Editorial Board Submissions: If a manuscript's author is an Editor-in-Chief or an Editorial Board member, the manuscript will be handled by an Assistant Editor or a Co-Editor-in-Chief. The authoring editor will be excluded from all publication decisions.
The Editor-in-Chief is responsible for the final decision on all manuscripts. This decision is based on the feedback from at least two expert reviewers. Possible decisions include:
● Accept: The manuscript is ready for publication.
● Minor Revisions: The manuscript can be accepted after minor changes are made.
● Major Revisions: The manuscript has potential but requires significant changes and will undergo a second round of review.
● Reject: The manuscript is not suitable for the journal.
All articles are published under a Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To sustain our open-access model, we charge an Article Processing Charge of USD 500 for each accepted manuscript. This single fee defrays the full cost of publication—from peer-review management and professional editing to typesetting, online hosting, and long-term digital preservation.
● APC Waiver Policy: We offer the following waiver options to support researchers globally:
○ For Low- and Middle-Income Countries: For submissions where the corresponding author is from a country classified by the World Bank or the United Nations as low- or middle-income, we may grant a full or partial APC waiver on a case-by-case basis.
○ Based on Research Quality and Contribution: For exceptionally outstanding research that makes a significant contribution to the field, the editorial board reserves the right to offer a discretionary APC waiver.
○ Special Circumstances: If an author is unable to pay the APC due to financial hardship, a written application with a detailed explanation and supporting documentation may be submitted to the editorial office for consideration. All waiver requests are treated confidentially and will not influence the editorial decision process.